Global Patent Index - EP 1087790 A2

EP 1087790 A2 20010404 - USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY

Title (en)

USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY

Title (de)

VERWENDUNG EINER VERBINDUNG MIT HOHER AFFINITÄT FÜR DEN MITOCHONDRIALEN BENZODIAZEPINE REZEPTOR IN EINEM ARZNEIMITTEL ZUR KREBS-THERAPIE

Title (fr)

UTILISATION D'UN COMPOSE POSSEDANT UNE AFFINITE POUR LE RECEPTEUR MITOCHONDRIAL DES BENZODIAZEPINES DANS UN MEDICAMENT POUR LA THERAPIE DU CANCER

Publication

EP 1087790 A2 20010404 (FR)

Application

EP 99923718 A 19990611

Priority

  • FR 9901383 W 19990611
  • FR 9807864 A 19980622

Abstract (en)

[origin: FR2779963A1] A Composition for treating cancer comprises a compound (A) with affinity for mitochondrial benzodiazepine receptors and an agent to induce apoptosis, for simultaneous, separate, or sustained use.

IPC 1-7

A61K 45/06

IPC 8 full level

A61K 31/47 (2006.01); A61K 45/06 (2006.01)

CPC (source: EP US)

A61K 31/47 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US)

C-Set (source: EP US)

A61K 31/47 + A61K 2300/00

Designated contracting state (EPC)

DE FR GB IT

DOCDB simple family (publication)

FR 2779963 A1 19991224; AU 3508999 A 20000106; CA 2274741 A1 19991222; EP 1087790 A2 20010404; US 6319931 B1 20011120; WO 9966958 A2 19991229; WO 9966958 A3 20000420

DOCDB simple family (application)

FR 9807864 A 19980622; AU 3508999 A 19990616; CA 2274741 A 19990614; EP 99923718 A 19990611; FR 9901383 W 19990611; US 33215299 A 19990614